Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > EPIAO® (Recombinant Human Erythropoietin Injection)
EPIAO® (Recombinant Human Erythropoietin Injection)
单价 面议对比
询价 暂无
发货
过期 长期有效
更新 2025-08-14 09:13
 
详细信息

Grade: Injection Grade

Factory Location: Shenyang Liaoning China

Main Sales Markets: Asia,Middle East,Africa

Sample Provided: no

No.1 market share (30%) in China(IMS data), approved in Brazil where GMP audit as strict as The US FDA, the closest in biochemical property, quality, efficacy and safety to the innovator Amgen’s EPO.